My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 20:15 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For 3SBio Inc.
3SBio Inc. (SSRX.O) (Nasdaq)
sector:
Healthcare
.
industry:
Pharmaceuticals - Diversified
ยท
View
SSRX
on other exchanges
As of 25 Nov 2009
13.57
USD
Price Change
+0.06
Percent Change
+0.44%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Xu, Liping
55
--
Vice President, Director
Huang, Bin
48
--
Vice President - Human Resources, Director
Wizel, Lawrence
66
--
Independent Director
Qi, Moujia
76
--
Independent Director
Yu, Mingde
63
--
Independent Director
Li, Ke
41
--
Corporate Secretary
Tong, Norman
40
2009
Controller
Su, Dongmei
39
--
Chief Technology Officer
Wei, Yingfei
48
2006
Chief Scientific Officer, Vice President - Business Development
Chen, David
44
2008
Chief Operating Officer, Executive Vice President
Tan, Bo
36
2009
Chief Financial Officer
Lou, Jing
46
--
Chief Executive Officer, Director
Lou, Dan
74
--
Chairman of the Board
Find out more about SSRX.O
Insider Trading